Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.48NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.16.31NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.16.25NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GA.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.37NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XAY.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.16.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18954Thailand
XBB.1.5.60NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FH.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CJ.1.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HZ.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.69NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.98NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.71NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HT.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.90NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FB.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.18.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.26NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EG.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.32NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.26.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EG.6NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FK.1.3.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FK.1.2.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FK.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.18NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.9NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
LP.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KP.3.1.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KP.3.1.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
LF.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JN.1.16NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KP.2.3.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
LQ.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
LY.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
MD.3.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
MK.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
LZ.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
MB.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KP.3.2.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JN.1.50NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KP.2.14NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
unclassifiableNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KS.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.1.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FY.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HH.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used